NMQ-22397-38888
3 vaccinations
2 coded responses
35 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 285 / NC
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Moderna
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
- 2021-01-13
-
2021-01-20
Dose 2 — Moderna
- 2021-01-21
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Site: Pain, Swelling · Muscle or body achesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-21
- 2021-07-21
-
2022-01-19
Dose 3 — Pfizer-BioNTech
- 2022-01-20
-
2022-01-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-01-21
- 2022-01-23
- 2022-01-24
- 2022-01-25
- 2022-01-28
- 2022-02-03
- 2022-02-09
- 2022-02-16
- 2022-02-23
- 2022-03-02
- 2022-04-20
- 2022-07-20
-
2023-01-21
Survey response — 12 months, dose 3MedDRA: Ageusia, Anosmia, Chest pain, Cough, Hypoacusis, Migraine, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-01-21
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2023-01-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-20 | Moderna | |
| 3 | 2022-01-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): No
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Hypoacusis | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release